Challenges and Countermeasures for Ensuring Health and Drug Stability During Long-term Space Missions

References

1. SchmidtC.F. LambertsenC.J. Pharmacology in space medicine.Annu. Rev. Pharmacol.19655138340410.1146/annurev.pa.05.040165.002123 14287889
   [Google Scholar]
2. CrucianB.E. ChoukèrA. SimpsonR.J. Immune system dysregulation during spaceflight: Potential countermeasures for deep space exploration missions.Front. Immunol.20189143710.3389/fimmu.2018.01437 30018614
   [Google Scholar]
3. WotringV. Space pharmacology: how space affects pharmacology.Drug Discovery and Evaluation: Methods in Clinical Pharmacology202051910.1007/978‑3‑319‑68864‑0_68
   [Google Scholar]
4. SaivinS. TraonA.P-L. Soulez-LaRivièreC. GüellA. HouinG. Pharmacology in space: Pharmacokinetics.Adv. Space Biol. Med.1997610712110.1016/S1569‑2574(08)60080‑5 9048136
   [Google Scholar]
5. AzzaouiK. JacobyE. SengerS. Scientific competency questions as the basis for semantically enriched open pharmacological space development.Drug Discov. Today20131817-1884385210.1016/j.drudis.2013.05.008 23702085
   [Google Scholar]
6. AbrahamS LinCY KleinHP VolkmannC TigranyanRA VetrovaEG Studies of specific hepatic enzymes involved in the conversion of carbohydrates to lipids in rats exposed to prolonged spaceflight aboard Cosmos 1129. Physiologist198023S55-8 (Suppl. 6)7243938
   [Google Scholar]
7. AdeyW.R. Studies on weightlessness in a primate in the Biosatellite 3 experiment.Life Sci. Space Res.197210678610.1515/9783112480144‑012 11898844
   [Google Scholar]
8. NicogossianAE ParkerJF Space physiology and medicine1982318
   [Google Scholar]
9. NelsonG.A. Space radiation and human exposures, a primer.Radiat. Res.2016185434935810.1667/RR14311.1 27018778
   [Google Scholar]
10. La TessaC. SivertzM. ChiangI.H. LowensteinD. RusekA. Overview of the NASA space radiation laboratory.Life Sci. Space Res. (Amst.)201611182310.1016/j.lssr.2016.10.002 27993189
    [Google Scholar]
11. FogtmanA. BaatoutS. BaseletB. Towards sustainable human space exploration—priorities for radiation research to quantify and mitigate radiation risks.NPJ Microgravity202391810.1038/s41526‑023‑00262‑7
    [Google Scholar]
12. FurukawaS. NagamatsuA. NenoiM. Space radiation biology for “Living in Space”.BioMed Res. Int.202020201470328610.1155/2020/4703286 32337251
    [Google Scholar]
13. DuranteM. CucinottaF.A. Physical basis of radiation protection in space travel.Rev. Mod. Phys.20118341245128110.1103/RevModPhys.83.1245
    [Google Scholar]
14. AdamczykA.M. NorburyJ.W. TownsendL.W. Weisskopf–Ewing and Hauser–Feshbach calculations of photonuclear cross sections used for electromagnetic dissociation.Radiat. Phys. Chem.201390212510.1016/j.radphyschem.2013.04.027
    [Google Scholar]
15. AdamczykA.M. NormanR.B. SriprisanS.I. NUCFRG3: Light ion improvements to the nuclear fragmentation model.Nucl. Instrum. Methods Phys. Res. A2012678213210.1016/j.nima.2012.02.021
    [Google Scholar]
16. TuY. WuJ. XuG. Perovskite solar cells for space applications: progress and challenges.Adv. Mater.20213321200654510.1002/adma.202006545 33861877
    [Google Scholar]
17. LiuM. JohnstonM.B. SnaithH.J. Efficient planar heterojunction perovskite solar cells by vapour deposition.Nature2013501746739539810.1038/nature12509 24025775
    [Google Scholar]
18. DongQ. FangY. ShaoY. Electron-hole diffusion lengths > 175 μm in solution-grown CH3NH3PbI3 single crystals.Science2015347622596797010.1126/science.aaa5760 25636799
    [Google Scholar]
19. KriegerS MakedonasG MehtaS Stress induced immune dysregulation: A continuum spanning Antarctica winterover, spaceflight, and terrestrial patients. J Immunol 2019; 202: 182.15.10.4049/jimmunol.202.Supp.182.15
    [Google Scholar]
20. PaulA.M. Cheng-CampbellM. BlaberE.A. Beyond low-earth orbit: Characterizing immune and microRNA differentials following simulated deep spaceflight conditions in mice.iScience2020231210174710.1016/j.isci.2020.101747 33376970
    [Google Scholar]
21. PaulAM Cheng-CampbellM BlaberEA Immune and microRNA differentials post-simulated deep spaceflight. J Immunol2021206(1_Supplement): 11.03(Suppl.)10.4049/jimmunol.206.Supp.11.03 33239422
    [Google Scholar]
22. MehtaS.K. CrucianB.E. StoweR.P. Reactivation of latent viruses is associated with increased plasma cytokines in astronauts.Cytokine201361120520910.1016/j.cyto.2012.09.019 23107825
    [Google Scholar]
23. HongM.Y. BancroftL.K. TurnerN.D. Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon.Nutr. Cancer200552216617510.1207/s15327914nc5202_7 16201848
    [Google Scholar]
24. ZwartS.R. PiersonD. MehtaS. GondaS. SmithS.M. Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-κB activation: From cells to bed rest to astronauts.J. Bone Miner. Res.20102551049105710.1359/jbmr.091041 19874203
    [Google Scholar]
25. JacobP OertlinC BaseletB WesterbergLS FrippiatJP BaatoutS Next generation of astronauts or ESA astronaut 2.0 concept and spotlight on immunity. NPJ Microgravity2023915110.1038/s41526‑023‑00294‑z
    [Google Scholar]
26. HicksJ. OlsonM. MitchellC. JuranC.M. PaulA.M. The impact of microgravity on immunological states.Immunohorizons2023710670682 37855736
    [Google Scholar]
27. BockP.M. MartinsA.F. SchaanB.D. Understanding how pre- and probiotics affect the gut microbiome and metabolic health.Am. J. Physiol. Endocrinol. Metab.20243271E89E10210.1152/ajpendo.00054.2024 38809510
    [Google Scholar]
28. KimS.K. GuevarraR.B. KimY.T. Role of probiotics in human gut microbiome-associated diseases.J. Microbiol. Biotechnol.20192991335134010.4014/jmb.1906.06064 31434172
    [Google Scholar]
29. SivamaruthiB.S. KesikaP. SuganthyN. ChaiyasutC. A review on role of microbiome in obesity and antiobesity properties of probiotic supplements.BioMed Res. Int.2019201912010.1155/2019/3291367 31211135
    [Google Scholar]
30. CunninghamM. Azcarate-PerilM.A. BarnardA. Shaping the future of probiotics and prebiotics.Trends Microbiol.202129866768510.1016/j.tim.2021.01.003 33551269
    [Google Scholar]
31. DouglasG.L. VoorhiesA.A. Evidence based selection of probiotic strains to promote astronaut health or alleviate symptoms of illness on long duration spaceflight missions.Benef. Microbes20178572773810.3920/BM2017.0027 28760005
    [Google Scholar]
32. GaignierF. SchentenV. De Carvalho BittencourtM. Gauquelin-KochG. FrippiatJ.P. Legrand-FrossiC. Three weeks of murine hindlimb unloading induces shifts from B to T and from th to tc splenic lymphocytes in absence of stress and differentially reduces cell-specific mitogenic responses.PLoS One201493e9266410.1371/journal.pone.0092664 24664102
    [Google Scholar]
33. LopezE.M. LeclercK. RamsukhM. Modulating the systemic and local adaptive immune response after fracture improves bone regeneration during aging.Bone202215711632410.1016/j.bone.2021.116324 34998981
    [Google Scholar]
34. GuderC. GraviusS. BurgerC. WirtzD.C. SchildbergF.A. Osteoimmunology: A current update of the interplay between bone and the immune system.Front. Immunol.2020115810.3389/fimmu.2020.00058 32082321
    [Google Scholar]
35. BucherC.H. SchlundtC. WulstenD. Experience in the adaptive immunity impacts bone homeostasis, remodeling, and healing.Front. Immunol.20191079710.3389/fimmu.2019.00797 31031773
    [Google Scholar]
36. PonzettiM. RucciN. Updates on osteoimmunology: What’s new on the cross-talk between bone and immune system.Front. Endocrinol. (Lausanne)20191023610.3389/fendo.2019.00236 31057482
    [Google Scholar]
37. SimpsonR.J. KunzH. AghaN. GraffR. Exercise and the regulation of immune functions.Prog. Mol. Biol. Transl. Sci.201513535538010.1016/bs.pmbts.2015.08.001 26477922
    [Google Scholar]
38. DrakeBG HoffmanSJ BeatyDW .Human exploration of Mars, Design Reference Architecture 5.0. IEEE aerospace conference Big Sky, MT, USA, 06-13 March201012410.1109/AERO.2010.5446736
    [Google Scholar]
39. HansonA. MindockJ. HaileyM. A model-based systems engineering approach to exploration medical system development.IEEE Aerospace Conference Big Sky, MT, USA201911910.1109/AERO.2019.8741864
    [Google Scholar]
40. BokserAD O’DonnellPB Remington: Essentials of Pharmaceutics.20133749
    [Google Scholar]
41. ReichardJ.F. PhelpsS.E. LehnhardtK.R. YoungM. EasterB.D. The effect of long-term spaceflight on drug potency and the risk of medication failure.NPJ Microgravity2023913510.1038/s41526‑023‑00271‑6
    [Google Scholar]
42. ScottJM FeivesonAH EnglishKL Effects of exercise countermeasures on multisystem function in long duration spaceflight astronauts.NPJ Microgravity2023911110.1038/s41526‑023‑00256‑5
    [Google Scholar]
43. WotringV.E. Chemical potency and degradation products of medications stored over 550 Earth days at the International Space Station.AAPS J.201618121021610.1208/s12248‑015‑9834‑5 26546565
    [Google Scholar]
44. WotringVE Space Pharmacology201210.1007/978‑1‑4614‑3396‑5
    [Google Scholar]
45. GandiaP. SaivinS. HouinG. The influence of weightlessness on pharmacokinetics.Fundam. Clin. Pharmacol.200519662563610.1111/j.1472‑8206.2005.00374.x 16313274
    [Google Scholar]
46. BlueR.S. BayuseT.M. DanielsV.R. Supplying a pharmacy for NASA exploration spaceflight: Challenges and current understanding.NPJ Microgravity201951410.1038/s41526‑019‑0075‑2
    [Google Scholar]
47. AzizS. RazaM.A. NoreenM. IqbalM.Z. RazaS.M. Astropharmacy: Roles for the pharmacist in space.Innov. Pharm.20221331310.24926/iip.v13i3.4956 36627911
    [Google Scholar]
48. Seoane-ViañoI. OngJ.J. BasitA.W. GoyanesA. To infinity and beyond: Strategies for fabricating medicines in outer space.Int. J. Pharm. X2022410012110.1016/j.ijpx.2022.100121 35782363
    [Google Scholar]
49. SrinivasanR.S. BourneD.W.A. PutchaL. PutchaL. Application of physiologically based pharmacokinetic models for assessing drug disposition in space.J. Clin. Pharmacol.199434669269810.1002/j.1552‑4604.1994.tb02025.x 8083402
    [Google Scholar]
50. RacineR.N. CormierS.M. Effect of spaceflight on rat hepatocytes: A morphometric study.J. Appl. Physiol.1992732S136S14110.1152/jappl.1992.73.2.S136 1526940
    [Google Scholar]
51. MerrillA.H. WangE. LaRocqueR. Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044.J. Appl. Physiol.1992732S142S14710.1152/jappl.1992.73.2.S142 1526942
    [Google Scholar]
52. SmirnovK.V. LizkoN.N. Problems of space gastroenterology and microenvironment.Nahrung1987315-656356610.1002/food.19870310572 3657934
    [Google Scholar]
53. ThorntonW.E. LinderB.J. MooreT.P. PoolS.L. Gastrointestinal motility in space motion sickness.Aviat. Space Environ. Med.1987589 Pt 2A16A21 3675484
    [Google Scholar]
54. EyalS. How do the pharmacokinetics of drugs change in astronauts in space?Expert Opin. Drug Metab. Toxicol.202016535335610.1080/17425255.2020.1746763 32223468
    [Google Scholar]
55. Dello RussoC. BandieraT. MoniciM. Physiological adaptations affecting drug pharmacokinetics in space: What do we really know? A critical review of the literature.Br. J. Pharmacol.2022179112538255710.1111/bph.15822 35170019
    [Google Scholar]
56. BlueRS ChancellorJC AntonsenEL BayuseTM DanielsVR WotringVE Limitations in predicting radiation-induced pharmaceutical instability during long-duration spaceflight.NPJ Microgravity2019511510.1038/s41526‑019‑0076‑1.
    [Google Scholar]
57. LeachC.S. InnersL.D. CharlesJ.B. Changes in total body water during spaceflight.J. Clin. Pharmacol.199131101001100610.1002/j.1552‑4604.1991.tb03663.x 1761710
    [Google Scholar]
58. DrummerC. HesseC. BaischF. Water and sodium balances and their relation to body mass changes in microgravity.Eur. J. Clin. Invest.200030121066107510.1046/j.1365‑2362.2000.00766.x 11122321
    [Google Scholar]
59. LarinaO.N. Blood plasma proteins following long-duration space flight Aviakosm. Ekolog. Med.20064061619 17405276
    [Google Scholar]
60. KohnF.P. HauslageJ. The gravity dependence of pharmacodynamics. The integration of lidocaine into membranes in microgravity.NPJ Microgravity201951510.1038/s41526‑019‑0064‑5
    [Google Scholar]
61. PolyakovA.V. SvistunovA.A. KondratenkoS.N. Study of the pharmacokinetics of various drugs under conditions of antiorthostatic hypokinesia and the pharmacokinetics of acetaminophen under long-term spaceflight conditions.Drug Metab. Pers. Ther.202237216317510.1515/dmpt‑2021‑0159 35737299
    [Google Scholar]
62. SumanasekeraW.K. SumanasekeraG.U. MattinglyK.A. DoughertyS.M. KeyntonR.S. KlingeC.M. Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity.Am. J. Physiol. Cell Physiol.20072932C566C57310.1152/ajpcell.00418.2006 17360813
    [Google Scholar]
63. PatelZ.S. BrunstetterT.J. TarverW.J. Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars.NPJ Microgravity2020611310.1038/s41526‑020‑00124‑6
    [Google Scholar]
64. SzocikK. WójtowiczT. Boone RappaportM. CorballyC. Ethical issues of human enhancements for space missions to Mars and beyond.Futures202011510248910.1016/j.futures.2019.102489
    [Google Scholar]
65. HalunkoV. IvanishchukA. HlobenkoI. OksiutenkoK. SaviukM. Mission to mars: Medical and legal aspects of the protection of human rights to life and health during long-lasting space missions.Advanced Space Law20211810.29202/asl/8/3
    [Google Scholar]
66. KhanM WotringVE FDA comprehensive stability evaluation of three medications2014182
    [Google Scholar]
67. DuB. DanielsV.R. VaksmanZ. BoydJ.L. CradyC. PutchaL. Evaluation of physical and chemical changes in pharmaceuticals flown on space missions.AAPS J.201113229930810.1208/s12248‑011‑9270‑0 21479701
    [Google Scholar]
68. PatelP. ButaniK. JadwaniK. Universe of space medicine: Emerging technologies in field of pharmacy.Res J Sci Technol202315314014410.52711/2349‑2988.2023.00023
    [Google Scholar]
69. SawyersL. AndersonC. BoydM.J. Astropharmacy: Pushing the boundaries of the pharmacists’ role for sustainable space exploration.Res. Social Adm. Pharm.20221893612362110.1016/j.sapharm.2022.02.002 35183459
    [Google Scholar]
70. McNultyM.J. XiongY.M. YatesK. Molecular pharming to support human life on the moon, mars, and beyond.Crit. Rev. Biotechnol.202141684986410.1080/07388551.2021.1888070 33715563
    [Google Scholar]
71. ThiagarajanH. HurlenE. Effects of microgravity on astronaut physiology in long-term space missions and proposed countermeasures.J Student Research2023123324210.47611/jsrhs.v12i3.4605
    [Google Scholar]
72. TomsiaM. CieślaJ. ŚmieszekJ. Long-term space missions’ effects on the human organism: What we do know and what requires further research.Front. Physiol.202415128464410.3389/fphys.2024.1284644 38415007
    [Google Scholar]
73. NeilsonB.N. CraigC.M. AltmanG.C. TravisA.T. VanceJ.A. KleinM.I. Can the biophilia hypothesis be applied to long-duration human space flight? A mini-review.Front. Psychol.20211270376610.3389/fpsyg.2021.703766 34566783
    [Google Scholar]
74. CriscuoloF. SueurC. BergouignanA. Human adaptation to deep space environment: An evolutionary perspective of the foreseen interplanetary exploration.Front. Public Health2020811910.3389/fpubh.2020.00119 32391303
    [Google Scholar]